Tonix Pharmaceuticals (TNXP) News Today $0.14 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Tonix Pharma Partners for Vaccine Clinical TrialNovember 4 at 10:06 PM | markets.businessinsider.comTonix Pharmaceuticals announces research agreement with KEMRINovember 4 at 5:01 PM | markets.businessinsider.comTonix Pharmaceuticals presents data on TNX-801 at World Vaccine CongressNovember 2 at 9:26 AM | markets.businessinsider.comTonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024November 1 at 7:00 AM | globenewswire.comTonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024October 31, 2024 | theglobeandmail.comStockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)October 30, 2024 | americanbankingnews.comTonix Pharmaceuticals to Present at BIO-Europe® 2024October 29, 2024 | globenewswire.comTonix Pharmaceuticals to Present at the 2024 ThinkEquity ConferenceOctober 25, 2024 | globenewswire.comEmpery Asset Management LP Acquires Shares in Tonix PharmaceuticalsOctober 16, 2024 | gurufocus.comTonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)October 16, 2024 | globenewswire.comTonix Pharmaceuticals Partners with X-Chem for AI-Driven Antiviral DevelopmentOctober 11, 2024 | msn.comTonix Pharma Enhances Drug Development with AI PartnershipOctober 9, 2024 | finance.yahoo.comWhy Tonix Pharmaceuticals (TNXP) Stock Is MovingOctober 8, 2024 | benzinga.comTonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum AntiviralsOctober 8, 2024 | globenewswire.comTonix Pharmaceuticals (TNXP) Has a Promising Pipeline but Faces Financial ChallengesOctober 1, 2024 | msn.comWhat's Going On With Tonix Pharmaceuticals Stock Friday?September 27, 2024 | msn.comTonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat MigrainesSeptember 27, 2024 | globenewswire.comTonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat MigrainesSeptember 19, 2024 | globenewswire.comTonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO's Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health EmergencySeptember 16, 2024 | globenewswire.comTonix Pharmaceuticals soars after positive data on its potential mpox vaccineSeptember 9, 2024 | msn.comTNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…September 9, 2024 | msn.comTonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeekSeptember 6, 2024 | globenewswire.comTonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)August 29, 2024 | globenewswire.comTonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox VaccineAugust 26, 2024 | msn.comTonix Collaborates With Bilthoven Biologicals To Advance Mpox Vaccine Candidate 'TNX-801'; Stock UpAugust 26, 2024 | markets.businessinsider.comTonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801August 26, 2024 | finance.yahoo.comTonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801August 26, 2024 | globenewswire.comTonix initiates Phase II trial for emergency cocaine intoxication treatmentAugust 22, 2024 | msn.comWhat's Going On With Tonix Pharmaceuticals (TNXP) Stock?August 21, 2024 | msn.comTonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)August 21, 2024 | finance.yahoo.comTonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine IntoxicationAugust 20, 2024 | finance.yahoo.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational HighlightsAugust 19, 2024 | finanznachrichten.deMpox vaccine developer Tonix surges 75% following outbreak spreadAugust 19, 2024 | msn.comTonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational HighlightsAugust 19, 2024 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News SummaryAugust 18, 2024 | benzinga.comTNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024August 16, 2024 | msn.comEU public health body lifts mpox risk alert level after new strain found in SwedenAugust 16, 2024 | msn.comEU public health body lifts mpox risk alert levelAugust 16, 2024 | msn.comTonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study SuggestsAugust 16, 2024 | benzinga.comTonix Pharma To Advance Development Of TNX-801 Vaccine Candidate Against Monkeypox, Stock GainsAugust 16, 2024 | markets.businessinsider.comTonix touts mpox shot's single-dose regimenAugust 16, 2024 | msn.comTonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health EmergencyAugust 16, 2024 | globenewswire.comTonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor SummitAugust 13, 2024 | finance.yahoo.comTonix Pharmaceuticals inks $50 million equity dealAugust 1, 2024 | uk.investing.comTonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™July 31, 2024 | globenewswire.comTonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on PainJuly 30, 2024 | finance.yahoo.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya for FibromyalgiaJuly 25, 2024 | finanznachrichten.deGlobal Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends ExpectedJuly 25, 2024 | theglobeandmail.comTonix Pharma gains on FDA fast track tag for pain therapyJuly 25, 2024 | msn.comTonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for FibromyalgiaJuly 25, 2024 | globenewswire.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address The Final Frontier (Ad)And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain. Here’s the full story for you. TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼0.000.46▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼62▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ProPhase Labs News InflaRx News Oncolytics Biotech News Aileron Therapeutics News Kazia Therapeutics News Purple Biotech News BeyondSpring News Protalix BioTherapeutics News Virios Therapeutics News MediciNova News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
